References

The role of case importation in explaining differences in early SARS-CoV-2 transmission dynamics in Canada—A mathematical modeling study of surveillance data

10.1016/j.ijid.2020.10.046 · 2021 · External reference

Regional variability in COVID-19 case fatality rate in Canada, February–December 2020

10.3390/ijerph18041839 · 2021 · External reference

COVID-19 in Canada: Experience and response to waves 2 and 3

10.1001/jama.2021.14797 · 2021 · External reference

COVID-19 in Canada—The fourth through seventh waves

10.1001/jamahealthforum.2022.4160 · 2022 · External reference

Unresolved reference

External reference

Modelling vaccination strategies for COVID-19

10.1038/s41577-022-00687-3 · 2022 · External reference

Optimizing influenza vaccine distribution

10.1126/science.1175570 · 2009 · External reference

Optimal H1N1 vaccination strategies based on self-interest versus group interest

10.1186/1471-2458-11-s1-s4 · 2011 · External reference

COVID-19 vaccination strategies depend on the underlying network of social interactions

10.1038/s41598-021-03167-1 · 2021 · External reference

Vaccine optimization for COVID-19: Who to vaccinate first?

10.1126/sciadv.abf1374 · 2021 · External reference

Optimizing age-specific vaccination

10.1126/science.abg2334 · 2021 · External reference

Assessing vaccination priorities for different ages and age-specific vaccination strategies of COVID-19 using an SEIR modelling approach

10.1371/journal.pone.0261236 · 2021 · External reference

COVID-19 vaccine allocation: Modeling health outcomes and equity implications of alternative strategies

2021 · External reference

The impact of vaccination on coronavirus disease 2019 (COVID-19) outbreaks in the United States

10.1093/cid/ciab079 · 2021 · External reference

Prioritizing COVID-19 vaccination efforts and dose allocation within Madagascar

10.1186/s12889-022-13150-8 · 2022 · External reference

Model-informed COVID-19 vaccine prioritization strategies by age and serostatus

10.1126/science.abe6959 · 2021 · External reference

What demographic, social, and contextual factors influence the intention to use COVID-19 vaccines: A scoping review

10.3390/ijerph18179342 · 2021 · External reference

Vaccine hesitancy in the era of COVID-19

10.1016/j.puhe.2021.02.025 · 2021 · External reference

10.3390/vaccines10081349

10.3390/vaccines10081349 · External reference

Attitudes, acceptance and hesitancy among the general population worldwide to receive the COVID-19 vaccines and their contributing factors: A systematic review

10.1016/j.eclinm.2021.101113 · 2021 · External reference

COVID-19 vaccine hesitancy in the United States: A systematic review

10.3389/fpubh.2021.770985 · 2021 · External reference

Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years

10.1126/science.abd7343 · 2020 · External reference

Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes

10.1126/science.abg8663 · 2021 · External reference

Long-term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: A modelling study

10.1371/journal.pmed.1004195 · 2023 · External reference

Past SARS-CoV-2 infection protection against re-infection: A systematic review and meta-analysis

10.1016/s0140-6736(22)02465-5 · 2023 · External reference

Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: A test-negative case-control study

10.1016/s1473-3099(22)00578-3 · 2023 · External reference

Protection against symptomatic infection with delta (B. 1.617. 2) and omicron (B. 1.1. 529) BA. 1 and BA. 2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021–March, 2022: A national, observational, test-negative, case-control study

10.1016/s1473-3099(22)00729-0 · 2023 · External reference

Which group should be vaccinated first?: A systematic review

10.3947/ic.2021.0029 · 2021 · External reference

Time trends in social contacts before and during the COVID-19 pandemic: The CONNECT study

10.1186/s12889-022-13402-7 · 2022 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

COVID-19 vaccination attitudes and intention among Quebecers during the first and second waves of the pandemic: Findings from repeated cross-sectional surveys

10.1080/21645515.2021.1947096 · 2021 · External reference

Waning antibody responses in COVID-19: What can we learn from the analysis of other coronaviruses?

10.1007/s15010-021-01664-z · 2022 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

Overview of Canada’s answer to the COVID-19 pandemic’s first wave (January–April 2020)

10.3390/ijerph18137131 · 2021 · External reference

COVID-19 and long-term care policy for older people in Canada

10.1080/08959420.2020.1764319 · 2020 · External reference

Approximate Bayesian computation scheme for parameter inference and model selection in dynamical systems

10.1098/rsif.2008.0172 · 2009 · External reference

Single-dose messenger RNA vaccine effectiveness against severe acute respiratory syndrome coronavirus 2 in healthcare workers extending 16 weeks postvaccination: A test-negative design from Québec, Canada

10.1093/cid/ciab739 · 2022 · External reference

Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario

10.1038/s41564-021-01053-0 · 2022 · External reference

Two-dose severe acute respiratory syndrome coronavirus 2 vaccine effectiveness with mixed schedules and extended dosing intervals: Test-negative design studies from British Columbia and Quebec, Canada

10.1093/cid/ciac290 · 2022 · External reference

Unresolved reference

External reference

Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)

10.1126/science.abb3221 · 2020 · External reference

Estimating the latent period of coronavirus disease 2019 (COVID-19)

10.1093/cid/ciab746 · 2022 · External reference

Distribution of incubation periods of COVID-19 in the Canadian context

10.1038/s41598-021-91834-8 · 2021 · External reference

The incubation period of COVID-19: A meta-analysis

10.1016/j.ijid.2021.01.069 · 2021 · External reference

The incubation period distribution of coronavirus disease 2019 : A systematic review and meta-analysis

10.1093/cid/ciab501 · 2021 · External reference

Estimating the latent period of coronavirus disease 2019 (COVID-19)

10.1093/cid/ciab746 · 2022 · External reference

Time between symptom onset, hospitalisation and recovery or death: Statistical analysis of Belgian COVID-19 patients

10.3390/ijerph17207560 · 2020 · External reference

Mortality trends and length of stays among hospitalized patients with COVID-19 in Ontario and Québec (Canada): A population-based cohort study of the first three epidemic waves

10.1016/j.ijid.2022.04.048 · 2022 · External reference

SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: A systematic review and meta-analysis

10.1016/s2666-5247(20)30172-5 · 2021 · External reference

Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)

10.1038/s41467-020-20568-4 · 2021 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA

10.1016/j.xcrm.2022.100583 · 2022 · External reference

COVID-19 seroprevalence in Canada modelling waning and boosting COVID-19 immunity in Canada a Canadian immunization research network study

10.3390/vaccines10010017 · 2021 · External reference

Modeling waning and boosting of COVID-19 in Canada with vaccination

10.1016/j.epidem.2022.100583 · 2022 · External reference

Occupation and COVID-19 mortality in England: A national linked data study of 14.3 million adults

10.1136/oemed-2021-107818 · 2022 · External reference

COVID-19 mortality and excess mortality among working-age residents in California, USA, by occupational sector: A longitudinal cohort analysis of mortality surveillance data

2022 · External reference

Predictors of vaccine acceptance, confidence, and hesitancy in general, and COVID-19 vaccination refusal in the province of Quebec, Canada

10.2147/ppa.s376103 · 2022 · External reference

Public preferences for a COVID-19 vaccination program in Quebec: A discrete choice experiment

10.1007/s40273-021-01124-4 · 2022 · External reference

Strategies intended to address vaccine hesitancy: Review of published reviews

10.1016/j.vaccine.2015.04.041 · 2015 · External reference

Identifying and addressing vaccine hesitancy

10.3928/00904481-20150410-07 · 2015 · External reference

Vaccine hesitancy

10.1016/j.mayocp.2015.09.006 · 2015 · External reference

Vaccine hesitancy: An overview

10.4161/hv.24657 · 2013 · External reference

Impact of a vaccine passport on first-dose SARS-CoV-2 vaccine coverage by age and area-level social determinants of health in the Canadian provinces of Quebec and Ontario: An interrupted time series analysis

2023 · External reference

Protection against SARS-CoV-2 after covid-19 vaccination and previous infection

10.1056/nejmoa2118691 · 2022 · External reference

Long-term protection associated with COVID-19 vaccination and prior infection

10.1001/jama.2022.14660 · 2022 · External reference

Effectiveness of the BNT162b2 vaccine after recovery from covid-19

10.1056/nejmoa2119497 · 2022 · External reference